Health
100 Most Popular
Pharmaceutical

Pfizer

$43.12
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.27 (0.63%) Today
+$0.03 (0.07%) As of 6:21 PM EDT after-hours

Why Robinhood?

You can buy or sell Pfizer and other stocks, options, ETFs, and crypto commission-free!

About PFE

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. Read More The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Employees
92,400
Headquarters
New York, New York
Founded
1849
Market Cap
237.95B
Price-Earnings Ratio
21.96
Dividend Yield
3.16
Average Volume
19.69M
High Today
$43.23
Low Today
$42.75
Open Price
$42.85
Volume
18.58M
52 Week High
$46.47
52 Week Low
$37.27

Collections

Health
100 Most Popular
Pharmaceutical
Manufacturing
Healthcare
Medical

PFE News

Washington PostJul 22

FDA approves 9 generic versions of nerve pain drug Lyrica

190
ReutersJul 19

Health Canada to keep importing Kaleo's epinephrine shot amid shortages

372
MarketWatchJul 11

EU OKs Glaxo buy of Pfizer unit, with conditions

600

PFE Earnings

$0.56
$0.66
$0.75
$0.85
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Available Jul 30, Pre-Market

Popular Stocks

More PFE News

MarketWatchJul 10

GlaxoSmithKline, Pfizer HIV drug in positive trial

678
Barron'sJul 8

Pfizer Looks Pretty Smart With Array BioPharma Purchase. Here’s Why.

158
Washington PostJul 3

Trump’s Bully Pulpit Didn’t Stop Drug-Price Hikes

581
ReutersJul 2

Pfizer's Wyeth loses bid to duck hormone-therapy lawsuit

431
ReutersJul 2

Senator Warren asks former FDA chief Gottlieb to resign from Pfizer board

206
ReutersJul 2

Pfizer, Sanofi, to boost South African Biovac's vaccine output

105
ReutersJul 2

GSK-Pfizer joint venture gets conditional approval from South Africa's competition regulator

83
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.